Background/Aims: Although EpCAM+CD44+ cells exhibit more stem-like properties than did EpCAM-CD44-cells, the specificity of EpCAM combined with CD44 in defining CSCs needs further improvement. Lgr5 is used as a biomarker to isolate cancer stem cells (CSCs) in colorectal cancer. However, it remains unclear whether Lgr5, along with EpCAM and CD44, can further identify and define CSCs in colorectal cancer. Methods: Lgr5+CD44+EpCAM+, Lgr5+CD44+EpCAM-, Lgr5+CD44-EpCAM+, Lgr5-CD44+EpCAM+, and Lgr5-CD44-EpCAMcells were separately isolated using fluorescence-activated cell sorting (FACS). Colony formation, self-renewal, differentiation, and tumorigenic properties of these cells were investigated through in vitro experiments and in vivo tumor xenograft models. The expression of stemness genes and CSC-and epithelial-mesenchymal transition (EMT)-related genes, such as KLF4, Oct4, Sox2, Nanog, CD133, CD44, CD166, ALDH1, Lgr5, E-cadherin, ZO-1, Vimentin, Snail, Slug, and Twist, was examined using real-time PCR. Results: Lgr5-positive subpopulations exhibited higher capacities for colony formation, self-renewal, differentiation, and tumorigenicity as well as higher expression of stemness genes and mesenchymal genes and lower expression of epithelial genes than did Lgr5-negative subpopulations. Conclusion: Our data revealed that tumorigenic cells were highly restricted to Lgr5-positive subpopulations. Most importantly, Lgr5+CD44+EpCAM+ cells exhibited more pronounced CSC-like traits than did any other subpopulation, indicating that Lgr5 combined with CD44 and EpCAM can further improve the stem-like traits of CSCs in colorectal cancer.
Introduction
Colorectal cancer is a genetic disease characterized by uncontrolled cell growth and the ability to invade other parts of the body by forming metastases [1] . Emerging evidence has shown that a subpopulation of cells, cancer stem cells (CSCs) or tumor-initiating cells, displays stem cell characteristics that influence tumorigenesis [2] . These cells possess specific properties, including self-renewal, differentiation potential, resistance to chemotherapy and high tumorigenicity. Further evidence has suggested an association between CSC phenotype and the progression of the epithelial-to-mesenchymal transition (EMT) [3, 4] , whereby epithelial cells lose their epithelial features and acquire mesenchymal features. More importantly, cancer cells can become more aggressive through the acquisition of mesenchymal properties and can thus promote tumor metastasis and progression [5] [6] [7] .
CSCs have been prospectively identified in colorectal cancer by their expression of specific surface markers, such as leucine-rich-repeat-containing G-protein-coupled receptor 5 (Lgr5), CD133, CD44, CD166, EpCAM (epithelial cell adhesion molecule), CD24, CD29, and aldehyde dehydrogenase (ALDH), among others [2, [8] [9] [10] . More recently, it was reported that Lgr5 showed promise as a biomarker for colorectal CSCs [9, 11, 12] . Moreover, increasing evidence has shown that Lgr5 is involved in the Wnt/β-catenin pathway, which plays a key role in maintaining CSC self-renewal and tumorigenic ability [13] [14] [15] . Therefore, Lgr5 seems to be a valuable biomarker for identifying and isolating human colorectal CSCs during cancer progression. However, it remains unclear whether Lgr5, along with other CSC markers, can further enhance tumor-initiation capacity and define CSCs in colorectal cancer.
EpCAM is expressed in many human cancers of epithelial origin. A recent study indicated that EpCAM is expressed in colorectal CSCs [16, 17] . Furthermore, Liu et al. demonstrated that EpCAM high /CD44+ cells were significantly correlated with the invasion and metastasis of colorectal cancer [18] . CD44 is a widely expressed protein with a role in cell-to-cell and cell-to-matrix interactions. CD44 overexpression increases tumor growth and anti-apoptotic properties. A recent study showed that CD133+CD44+ cells isolated from human colorectal cancer cell line exhibited CSC properties [2] .
It is generally considered that the identification and characterization of colorectal CSCs may lead to revolutionary findings in targeted therapeutic strategies [19] [20] [21] . However, a long-standing problem has been the paucity of specific markers with which to identify and isolate colorectal CSCs and to investigate their involvement in cancer progression [22] . To determine more specific CSC markers, in this study, we first examined whether colorectal CSCs could be further identified and defined using Lgr5 combined with CD44 and EpCAM.
Materials and Methods

Ethics statement
This study was conducted in strict accordance with the protocol approved by the Committee on the Ethics of Animal Experiments of the University of Huazhong University of Science and Technology (Permit Number: S255). All surgery was performed under a mixture of ketamine and chlorpromazine anesthesia, and all efforts were made to minimize suffering [8] .
Reagent at room temperature for 15 min, followed by incubation with antibodies (human anti-CD44-APC and human anti-EpCAM-Alexa Fluor 488, eBioscience, Thermo Fisher Scientific, MA, USA; and human antiLgr5-PE, BD, San Jose, CA, USA) at 4°C for 30 min. Then, 7AAD staining was performed to exclude dead cells. After staining, cells were subjected to flow cytometry analysis using BD FACSVerse (BD, USA). For sorting, cells were collected using a BD FACSAria Fusion flow cytometer (BD, USA) and then cultured in serum-free DMEM/F12 medium containing 20 ng/ml epidermal growth factor (EGF, PeproTech, Inc., Rocky Hill, NJ, USA), 10 ng/ml basic fibroblast growth factor (bFGF, PeproTech, USA), 5 μg/ml insulin (Sigma, Merck kGaA, Darmstadt, Germany), 0.4% bovine serum albumin (BSA, Amresco, Solon, OH, USA), 100 U/ml Pen/Strep (HyClone, USA), and 2% B27 (Invitrogen, Thermo Fisher Scientific, MA, USA) for 2 days before transfection.
Sphere-forming assay
Single cells (500 cells per well) were plated in 6-well plates and cultured in serum-free DMEM/F12 medium (as detailed above) for 7 days. At the end of the experiment, the number of spheres per well was counted.
Limiting dilution assay
The LDA and tumor sphere-forming assays were performed as previously described, with some modifications [23] . In brief, limiting dilutions of tumor cells were plated (4 to 0.5 cells per well) in 0.2 ml of serum-free DMEM/F12 medium as described for the sphere-forming assay and were cultured for 7 days. At the end of the experiment, the number of spheres per well was counted. The fraction of negative wells compared with the cell dilution was graphed and fitted with a linear regression model to estimate CSC frequency. Following the assumption that a single stem cell gives rise to one sphere [24] , the proportion of negative wells was defined by the zero point ( , where x is the mean number of cells per well. One CSC (one sphere) was expected at a dilution of 0.37 (when x=1, F 0 =e -1 =0.37).
Colony formation assay
The colony formation assay was performed as previously described [8] . Briefly, single cells (500 cells per well) were plated in 6-well plates and cultured for 2 weeks. After crystal violet staining, the cells were photographed, and the in vitro tumorigenic efficiency was analyzed.
Immunofluorescence staining and laser confocal microscopy Lgr5+CD44+EpCAM+ cells were sorted and smeared before being fixed with 2% paraformaldehyde at 37°C for 15 min. The fixed cells were then permeabilized with 0.1% Triton X-100 at room temperature for 15 min, followed by incubation at 4°C for 10 h with primary antibodies against Vimentin (1:200, Cell Signaling Technology, MA, USA) and Lgr5 (1:200, Santa Cruz Biotechnology, CA, USA). The cells were then incubated with Alexa Fluor 488-(1:200, Cell Signaling Technology, USA) or DyLight 649-conjugated secondary antibodies (1:200, Multi Sciences, China) at 37°C for 30 min. These slides were then mounted with Prolong Gold with 4',6-diamidino-2-phenylindole (DAPI, Invitrogen, USA). Fluorescent images were obtained using an FV1200 laser confocal microscope (Olympus, Tokyo, Japan).
Real-time migration and invasion assay
The migration and invasion rates of each population were assessed using the xCELLigence system (RTCA DP Station, Roche, IN, USA) as previously described [25, 26] . This assay provides a real-time measurement of each population's migration and invasion by extrapolating the number of cells passing through a porous membrane from the electrical impedance data. Briefly, 150 μl of RPMI 1640 complete medium was added to the lower chamber of a cellular migration and invasion plate (Roche). The upper chamber was coated with (invasion) or without (migration) 10 μl of Matrigel (Sigma) and incubated for 15 h. The upper chamber was then loaded with 50 μl of serum-free RPMI 1640 medium and fitted onto the lower chamber. After 30 min of equilibration, 2×10 4 cells from each subpopulation were plated onto each well of the upper chamber. The plates were subsequently placed on the RTCA analyzer under humidified conditions at 37°C and 5% CO 2 . The cellular migration and invasion of each subpopulation was recorded every 20 min.
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Cellular Physiology and Biochemistry well plates containing complete medium and cultured for 72 h. The absorption (OD value) at 450 nm was measured for each well using a plate reader and then graphed [27] .
Soft agar assay
The soft agar assay was performed as previously described [8] . Briefly, each well of a 6-well plate was loaded with 2 ml of 0.5% agar (w/v) in RPMI 1640 supplemented with 10% FBS as a base. After polymerization of the base agar, 1×10 3 cells mixed in 2 ml of 0.375% agar (w/v) in RPMI 1640 supplemented with 10% FBS were added. Cultures were maintained in a humidified incubator at 37°C and 5% CO 2 for 2 weeks before colonies were counted and photographed.
RNA isolation and qRT-PCR
Total mRNA was extracted from cells and then reverse-transcribed to cDNA with PrimeScript RT Master Mix (Roche) according to the manufacturer's instructions. qRT-PCR was performed to quantify the expression of stemness genes and EMT genes using LightCycler FastStart DNA Master PLUS SYBR Green I (Roche) according to the manufacturer's protocol on a Roche LightCycler 96 (Roche). Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used as an internal control for the normalization of these genes. PCR amplification was conducted under the following conditions: 1 cycle of pre-incubation at 95°C for 10 min, followed by 40 cycles of denaturation for 10 sec at 95°C, annealing for 10 sec at 60°C, and extension for 10 sec at 72°C. Primer sequences and specifications are summarized in Table 1 . For each sample, duplicate reactions were performed, and the average mRNA level of each gene was determined using the 2-ΔΔCt method with the Lgr5-CD44-EpCAM-subpopulation as a control group.
In vivo tumor cell xenograft model
All animal experiments were approved by the Ethics Committee of Huazhong University of Science and Technology (#S255; Wuhan, China). A total of 5×10 5 cells in 100 ml of PBS were subcutaneously transplanted into 4-week-old female Balb/c nu/nu mice (n=5 mice per group) (Beijing HFK Bioscience Co., Ltd, China). Mice were housed in a specific-pathogen-free, environmentally controlled facility [28] . Mice were sacrificed with an intraperitoneal injection of pentobarbital sodium (100 mg/kg, Sigma), and grafts were removed when the tumors reached a length of 2.0 cm or 60 days after injection, whichever occurred first [8] . Harvested tumors were prepared for histopathologic analysis. Tumor volume was calculated using the following formula: tumor volume=length×width 2 ×0.5.
Statistical analysis
Statistical analyses were performed using SPSS software, version 19.0. All data with a normal distribution are presented as the means ± s.d., comparisons among groups were analyzed using one-way ANOVA, and pairwise comparisons were performed using a paired-samples t-test. Data with a value of P<0.05 were considered statistically significant.
Results
Lgr5 strictly defines stemness in EpCAM+CD44+ and EpCAM-CD44-subpopulations
Some researchers demonstrated that EpCAM and CD44 expression were significantly correlated with the invasion and metastasis of colorectal cancer [18] . Although EpCAM and CD44 are thought to act as a marker of colorectal CSCs, the stem-like properties of (Fig. 1B) . However, a portion of EpCAM+CD44+ cells did not generated spheres, while a portion of EpCAM-CD44-cells generated spheres, indicating that the specificity of EpCAM combined with CD44 is not sufficient to define CSCs and needs to be further improved (Fig. 1B) . We then asked whether Lgr5 could further define CSCs in EpCAM+CD44+ and EpCAM-CD44-subpopulations. Lgr5+ and Lgr5-cells were sorted from both EpCAM+CD44+ and EpCAM-CD44-subpopulations. As shown in Fig. 1C , the Lgr5+ cells sorted from the two subpopulations generated spheres and colonies, while Lgr5-cells rarely generated either spheres or colonies. These data indicated that Lgr5 strictly defines stemness in both EpCAM+CD44+ and EpCAM-CD44-subpopulations. However, the Lgr5+EpCAM+CD44+ subpopulation generated more spheres and colonies than the Lgr5+EpCAM-CD44-subpopulation.
To further study whether Lgr5 combined with CD44 and EpCAM could improve the specificity of defining CSCs, the expression of CSC markers (including Lgr5, CD44, and EpCAM) was analyzed in human colorectal cancer cells and used for sorting by flow cytometry [8, 9, 18] . For convenience, we designated Lgr5+CD44+EpCAM+, Lgr5+CD44+EpCAM-, Lgr5+CD44-EpCAM+, Lgr5-CD44+EpCAM+, and Lgr5-CD44-EpCAM-cells as subpopulations 1-5 (S1-S5), respectively. The percentages of each subpopulation are summarized in Table 2 . Sorted cells (S1-S5) were used for further study.
Expression of stemness genes and CSC genes in each subpopulation
To understand differences in the expression of stemness genes and EMT genes in each subpopulation, quantitative real-time PCR (qRT-PCR) was performed to investigate mRNA levels in these cells. The results in Fig. 2 indicate that both stemness genes, such as Oct4, Sox2, Nanog, and KLF4, and CSC genes, such as CD133, CD44, CD166, ALDH1, and Lgr5, were more highly expressed in Lgr5-positive subpopulations. Moreover, stemness genes were extremely overexpressed in Lgr5+CD44+EpCAM+ (S1) compared with their expression in the other subpopulations. 
Self-renewal properties and frequencies of CSCs in each subpopulation
The defining feature of CSCs is self-renewal, which is responsible for cancer recurrence and metastasis [16, 29] . To examine the selfrenewal properties of each subpopulation, we performed sphere-forming assays. Our data demonstrated that Lgr5-positive cells (S1, S2, and S3) generated significantly more multipotent spheres than did Lgr5-negative cells (S4 and S5). More importantly, the S1 subpopulation generated the maximum number of spheres, indicating a selfrenewal advantage in Lgr5+CD44+EpCAM+ cells (Fig. 3A) .
Since a sphere is thought to represent all the progeny from a single stem cell, sphere formation reflects the stem cell population [30] . Thus, CSC frequency can be estimated through a limiting dilution assay [24] . Our data showed that the median CSC frequencies of the S1 (10/121), S2 (10/133), and S3 (10/137) subpopulations were much higher than those of the S4 (10/238) and S5 (10/250) subpopulations (Fig. 3B) . Stemness genes, such as Oct4, Sox2, Nanog and KLF4, were expressed more highly in Lgr5-positive cells (S1, S2 and S3) than in Lgr5-negative cells (S4 and S5), as assessed by qRT-PCR.
(B) CSC genes, such as CD133, CD44, CD166, ALDH1, and Lgr5, were expressed more highly in Lgr5-positive cells than in Lgr5-negative cells, except for CD44 expression in the S3 subpopulation. #P<0.05 compared to any other group. **P<0.05. The S5 subpopulation was used as a control group. 
Colony formation and proliferation properties in each subpopulation
We then investigated the malignant profile of each subpopulation, including its ability to form colonies and proliferate [8, 31] . We found that the S1, S2 and S3 subpopulations had a significantly higher colony formation capacity than did the S4 and S5 subpopulations, as assessed by the soft agar assay and colony formation assay (Fig. 4A-4B ). S1 cells generated the maximum number of colonies, indicating an advantage of Lgr5+CD44+EpCAM+ cells in colony formation and proliferation. 
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We then evaluated the proliferation capacity of each subpopulation using the CCK-8 assay [8] . We cultured 2×10 3 cells from each subpopulation in 96-well plates to compare cell proliferation and repeated this assay 10 times. The results in Fig. 4C indicated that Lgr5-positive cells (S1, S2, and S3) exhibited a significantly higher proliferation capacity than did Lgr5-negative cells (S4 and S5). Additionally, Lgr5+CD44+EpCAM+
(S1) cells could proliferate more rapidly than any other subpopulation.
Mesenchymal characteristics in each subpopulation
EMT has been reported as a mechanism by which cancer cells acquire invasive and stem-like characteristics [3] . Some researchers have also demonstrated a partial overlap between mesenchymal characteristics and CSC characteristics [3, 4] . Thus, we investigated mesenchymal characteristics, such as EMT-related gene expression, migration and invasion, in each subpopulation. As shown in Fig. 5A , mesenchymal genes, such as Vimentin, Snail, Slug, and Twist, were more highly expressed in Lgr5-positive cells (S1, S2 and S3) than in Lgr5-negative cells (S4 and S5), while the epithelial genes E-cadherin and ZO-1 were more highly expressed in Lgr5-negative cells. Moreover, the co-expression of Lgr5 and Vimentin in S1 cells was confirmed by immunofluorescence (Fig. 5B) . Finally, we demonstrated that Lgr5-positive cells (S1, S2 and S3) exhibited a higher capacity for migration and invasion than did Lgr5-negative cells (S4 and S5), as assessed by real-time migration and invasion assays, respectively. More importantly, the S1 subpopulation could migrate and invade more rapidly than other subpopulations (Fig. 5C ).
Tumor-initiating capacity of cell subpopulations expressing CSC markers
Finally, the tumor formation capacity of the putative CSC subpopulations was evaluated in immunodeficient mice [32] . Titrated numbers of triple-positive (S1) cells and their counterparts were subcutaneously injected into C57BL/6 nude mice. The injected S2 and S3 cells displayed significantly delayed tumor growth compared with that of the triple-positive cells. Most importantly, no tumor growth was observed after the injection of 1×10 7 S4 and S5 cells (Fig. 6A-6B ). To further assess the effects of CSC subpopulations in tumor xenografts, single cells derived from xenograft tumors were replated in sphere culturing conditions. As expected, the sphere-forming capacity of Lgr5+CD44+EpCAM+ cells was sharply increased compared with that of the S2 and S3 cells, indicating a higher capacity for self-renewal (Fig.  6C) . Collectively, these results indicated that Lgr5-positive cells exhibited higher tumorigenic potential than did Lgr5-negative cells in vivo and that the Lgr5+CD44+EpCAM+ subpopulation exhibited a higher tumor-initiating capacity than did the other subpopulations.
Discussion
The metastasis and recurrence associated with human colorectal cancer plays a key role in cancer-related mortality [1, 33] . Increasing evidence suggests that only a small subpopulation of cancer cells can regenerate [22] . These cells, termed CSCs, are thought to cause the initiation, therapeutic resistance, metastasis, and recurrence of cancer [2, 34, 35] . Accordingly, it is crucial to identify markers specific to CSCs to facilitate the development of targeted cancer therapies [5, 16] . The objectives of this study were to evaluate the expression of surface biomarkers (including Lgr5, CD44, and EpCAM) in human colorectal CSCs and to investigate their correlation with functional stem-like characteristics. In recent years, studies have revealed that Lgr5 is overexpressed in various tumor types, including colorectal cancer, hepatocellular carcinoma, and esophageal adenocarcinoma [9, 11, 13, 36] . Studies in mice have demonstrated that Lgr5 might be another marker of both normal colon stem cells and colon CSCs [37] . Indeed, Lgr5 is a member of the Wnt/β-catenin pathway, which plays a key role in maintaining CSC self-renewal and tumorigenic ability [9, 13, 38, 39] . Kemper et al. isolated a distinct subpopulation of EpCAM+Lgr5+ cells from primary human colorectal cancer cells and confirmed that Lgr5 overexpression induced the malignant cancer profile [9] . EpCAM was reported to be overexpressed in human breast and colon CSCs [16] . Moreover, Yamashita et al. found that EpCAM expression was regulated by the Wnt/β-catenin pathway and that EpCAM+ hepatocellular carcinoma cells were tumor-initiating cells with stem-like features [40] . Thus, EpCAM may act downstream of the Wnt/β-catenin pathway to maintain stemness and could serve as a useful marker for colorectal CSCs. Recently, Liu et al. reported that the presence of EpCAM+CD44+ cells was significantly correlated with the depth of invasion, clinical stage, degree of differentiation, and metastatic status in colorectal cancer [18] . In addition, double-positive cells were detected in the corresponding liver metastases [18] . Previous studies have confirmed that EpCAM+CD44+ colorectal cancer cells have stemlike properties, leading to the tumorigenesis, migration, invasion and metastasis of human colorectal cancer [16, 41, 42] . These data suggest that EpCAM+CD44+ may be used as a reliable marker of colorectal CSCs [16] . More importantly, scientists have demonstrated that the combined and sequential use of CSC markers led to higher purified CSC subpopulations than any single biomarker [43, 44] . To date, no study has investigated the characteristics of colorectal CSCs expressing Lgr5 combined with CD44 and EpCAM. In this study, we performed a systematic evaluation to better characterize and determine the utility of Lgr5 along with CD44 and EpCAM in identifying CSCs from the DLD-1 human colorectal cancerderived cell line.
The critical feature of CSCs is self-renewal, which is responsible for cancer drug resistance, metastasis, and recurrence [19, 20, 45] . We found that Lgr5-positive subpopulations generated significantly more multipotent spheres than did Lgr5-negative subpopulations, indicating a remarkable self-renewal advantage of Lgr5-positive cells. Moreover, the Lgr5+CD44+EpCAM+ subpopulation displayed a higher self-renewal capacity than did any other subpopulations (Fig. 3A) . We also performed a traditional and reliable limiting dilution assay (LDA) to determine the fraction of CSCs in each subpopulation. The LDA results revealed the frequency of sphere formation, providing useful information for interpreting the composition of the mixed population of CSCs [23, 46] . Our current data showed that Lgr5-positive subpopulations possessed a higher percentage of CSCs than did Lgr5-negative subpopulations. The CSC median frequencies of S1 (10/121), S2 (10/133), and S3 (10/137) were higher than those of the S4 (10/238) and S5 (10/250) subpopulations. The CSC fraction was dramatically increased in the Lgr5+CD44+EpCAM+ subpopulation compared with that of the other subpopulations (Fig. 3B) .
Stemness genes, such as Oct4, Sox2, c-Myc, and KLF4, have been recognized as "pluripotency factors" that play critical roles in maintaining the self-renewal capacity of stem cells [47] . We demonstrated that the expression of stemness genes was higher in Lgr5-positive cells and markedly increased in Lgr5+CD44+EpCAM+ cells compared with that in other subpopulations, which is consistent with the data from the LDA and the sphere-forming assay ( Fig. 2A) . Previous studies have demonstrated correlations between the maintenance of human CSC stemness and the expression of multipotency genes [48] [49] [50] . Saiki et al. showed that Sox2 expression was highly associated with lymph node metastasis and Dukes stage in Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry human colorectal cancer [50] . Another study revealed correlations between the expression of Oct4, Sox2, and CD133 and poor prognosis of colorectal cancer patients [49] . The EMT has been postulated as a mechanism by which cancer cells acquire the invasive and stem-like traits necessary for distant metastasis [3] . The EMT process is characterized by decreases in epithelial genes, such as ZO-1 and E-cadherin, combined with the acquisition of mesenchymal markers, such as Vimentin, Snail and Slug [6, 8] . More importantly, the EMT is correlated with increases in malignant cancer phenotypes, such as migration, invasion, and metastasis [51] . Decreased expression of mesenchymal markers or the re-expression of E-cadherin was shown to reduce the cancer invasion phenotype [31, 51] , indicating that these genes play a critical role in controlling the malignant profiles of cancer cells. Some researchers have indicated that CSCs might be generated through processes that are related to activation of the EMT [3, 4] . Thus, CSC biology and the EMT are thought to be mechanistically correlated and key components of cancer migration, invasion, and metastasis [5, [52] [53] [54] . Accordingly, in-depth research into the crosstalk between cancer stemness and the EMT is essential for a better understanding of tumor progression. Our findings also demonstrated that Lgr5-positive cells displayed higher expression of Vimentin, Snail and Slug as well as decreased expression of ZO-1 and E-cadherin compared with that of Lgr5-negative cells. In addition, we identified the co-expression of Lgr5 and the mesenchymal marker Vimentin through immunofluorescence staining. Furthermore, triple-positive cells migrated and invaded significantly more rapidly than their negative counterparts, which corresponds to previous results [25, 55] . Collectively, our data suggest a partial overlap between the transcriptional programs underlying the EMT and Lgr5-positive cells.
CSCs are a subset of cells with indefinite passaging ability; they can continuously proliferate and differentiate [2, 29] . Therefore, CSCs have been identified as key factors in cancer growth and metastasis [56] . Accordingly, we assessed the proliferative capacity of each subpopulation using the CCK-8 assay. We found that Lgr5-positive cells had a significantly higher proliferative capacity than Lgr5-negative cells. More importantly, triple-positive cells had a significantly higher capacity to proliferate and differentiate than their negative counterparts (Fig. 4) . These findings are further supported by the in vitro tumorigenicity assay and in vivo tumor formation study in mice. Using the colony formation assay and soft agar assay, we found that Lgr5-positive cells had a significantly higher colony formation capacity than Lgr5-negative cells and that the Lgr5+CD44+EpCAM+ subpopulation could generate more colonies than any other subpopulation, indicating a higher tumorigenic potential in vitro. Moreover, we found that tumors formed earlier and were significantly larger in mice transplanted with Lgr5+CD44+EpCAM+ cells than in mice transplanted with Lgr5+CD44+EpCAM-or Lgr5+CD44-EpCAM+ cells. In addition, no tumor growth was observed after injection of even 1×10 7 Lgr5-CD44+EpCAM+ or Lgr5-CD44-EpCAM-cells (data not shown). The volumes of the tumors generated by 5×10 5 cells from each subpopulation are shown in Fig. 6 .
For the first time, our systematic experimental data have shown that Lgr5 expression is highly restricted to colorectal CSCs. Most importantly, CSCs could be further identified and defined using Lgr5 combined with CD44 and EpCAM, which might open a new avenue for colorectal cancer cell eradication by targeting Lgr5+CD44+EpCAM+ cells.
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